Daniel Joseph OConnell
President and CEO at Acumen Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Acumen Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acumen Pharmaceuticals Inc. June 4, 202499.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −2,689 | $1.88 | $5,055 |
| Jan 21, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −9,346 | $1.81 | $16,916 |
| Jan 20, 2026 | Acumen Pharmaceuticals Inc. | Grant or award | +299,800 | — | — |
| Jan 12, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −5,388 | $1.73 | $9,321 |
| Jan 9, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −12,941 | $1.76 | $22,776 |
| Jan 8, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −8,143 | $1.82 | $14,820 |
| Jan 7, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −37,755 | $1.99 | $75,132 |
| Jan 6, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −5,102 | $1.97 | $10,051 |
| Jan 5, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −4,649 | $1.97 | $9,159 |
| Jan 21, 2025 | Acumen Pharmaceuticals Inc. | Open-market sale | −12,619 | $1.59 | $20,064 |
| Jan 7, 2025 | Acumen Pharmaceuticals Inc. | Grant or award | +225,400 | — | — |
| Jan 3, 2025 | Acumen Pharmaceuticals Inc. | Open-market sale | −47,778 | $1.84 | $87,912 |
| Jan 19, 2024 | Acumen Pharmaceuticals Inc. | Open-market sale | −15,200 | $3.47 | $52,744 |
| Jan 2, 2024 | Acumen Pharmaceuticals Inc. | Grant or award | +401,000 | — | — |
| Jan 17, 2023 | Acumen Pharmaceuticals Inc. | Grant or award | +114,000 | — | — |
Questions about Daniel Joseph OConnell
What boards is Daniel Joseph OConnell on?
Daniel Joseph OConnell sits on the board of Acumen Pharmaceuticals Inc.
What company is Daniel Joseph OConnell the CEO of?
Daniel Joseph OConnell is President and CEO of Acumen Pharmaceuticals Inc.
How long has Daniel Joseph OConnell served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.